Strengthening The Herbal Industry Through Clinical Trials

Clinical trials are essential for establishing the safety, efficacy, and quality of medicinal products, including herbal medicines that are increasingly used worldwide. Although herbal drugs are often perceived as safe due to their natural origin and long history of traditional use, growing evidence indicates the potential for adverse effects, drug–herb interactions, and variability in therapeutic outcomes. The expanding global market for herbal products has intensified the need for systematic clinical evaluation to support their integration into mainstream healthcare. This review discusses the scope, necessity, and methodological aspects of clinical trials in the herbal industry, highlighting challenges such as product standardization, quality control, ethical concerns, regulatory requirements, and study design complexities. It also outlines international and national guidelines, particularly those issued by the World Health Organization and regulatory frameworks in India under the Department of AYUSH. Emphasis is placed on the importance of rigorous scientific validation, appropriate regulatory oversight, and ethical conduct in herbal clinical research. Strengthening clinical trial methodologies and harmonizing regulatory standards are crucial to bridging traditional knowledge with evidence-based medicine and ensuring the global acceptance of herbal therapeutics